Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10044552HBVENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TVIS10052789HBVENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TVIS30073184HIVENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TVIS44024288HTLV-1ENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TCGA Plot Options
Drug Information
GeneAR
DrugBank IDDB01406
Drug NameDanazol
Target IDBE0000132
UniProt IDP10275
Regulation Typeagonist
PubMed IDs2486535; 18061638; 10882672; 9593936; 2404115
CitationsDonaldson VH: Danazol. Am J Med. 1989 Sep;87(3N):49N-55N.@@Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S, Mizuguchi K: Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids. 2008 Feb;73(2):222-31. Epub 2007 Oct 22.@@Gomez F, Ruiz P, Lopez R, Rivera C, Romero S, Bernal JA: Effects of androgen treatment on expression of macrophage Fcgamma receptors. Clin Diagn Lab Immunol. 2000 Jul;7(4):682-6.@@Roselli CE: The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area. Brain Res. 1998 May 11;792(2):271-6.@@Dmowski WP: Danazol. A synthetic steroid with diverse biologic effects. J Reprod Med. 1990 Jan;35(1 Suppl):69-74; discussion 74-5.
GroupsApproved
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Pathways
PharmGKBPA164749056
ChEMBLCHEMBL1479